Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D.

Nature. 1994 Oct 6;371(6497):508-10.

PMID:
7935762
2.

Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles.

McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D.

J Infect Dis. 1999 Jan;179(1):287-90.

PMID:
9841857
3.

Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.

Aidoo M, McElroy PD, Kolczak MS, Terlouw DJ, ter Kuile FO, Nahlen B, Lal AA, Udhayakumar V.

Genet Epidemiol. 2001 Nov;21(3):201-11.

PMID:
11668577
4.

Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand.

Hananantachai H, Patarapotikul J, Ohashi J, Naka I, Krudsood S, Looareesuwan S, Tokunaga K.

Tissue Antigens. 2007 Mar;69(3):277-80.

PMID:
17493155
5.

TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.

McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D.

Eur J Immunol. 1996 Sep;26(9):2113-8.

PMID:
8814255
6.

A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.

Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D.

Nat Genet. 1999 Jun;22(2):145-50.

PMID:
10369255
7.

Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese.

Hamaguchi K, Kimura A, Seki N, Higuchi T, Yasunaga S, Takahashi M, Sasazuki T, Kusuda Y, Okeda T, Itoh K, Sakata T.

Tissue Antigens. 2000 Jan;55(1):10-6.

PMID:
10703602
8.

Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar.

Ubalee R, Suzuki F, Kikuchi M, Tasanor O, Wattanagoon Y, Ruangweerayut R, Na-Bangchang K, Karbwang J, Kimura A, Itoh K, Kanda T, Hirayama K.

Tissue Antigens. 2001 Dec;58(6):407-10.

PMID:
11929592
9.

Associations between frequencies of a susceptible TNF-alpha promoter allele and protective alpha-thalassaemias and malaria parasite incidence in Vanuatu.

Ubalee R, Tsukahara T, Kikuchi M, Lum JK, Dzodzomenyo M, Kaneko A, Hirayama K.

Trop Med Int Health. 2005 Jun;10(6):544-9.

10.
11.
12.

[Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].

Aguillón JC, Cruzat A, Cuenca J, Cuchacovich M.

Rev Med Chil. 2002 Sep;130(9):1043-50. Review. Spanish.

PMID:
12434654
13.

Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma.

Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, Burton PR, Goldblatt J, Lesouëf PN.

Clin Exp Allergy. 1998 May;28(5):578-84.

PMID:
9645594
14.

TNF-alpha alleles and susceptibility to cerebral malaria.

Sinha S.

Natl Med J India. 1995 Mar-Apr;8(2):70-2. No abstract available.

PMID:
7735066
15.

Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease.

Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K.

Genes Immun. 2000 Aug;1(6):351-7.

16.
17.

IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria.

Koch O, Awomoyi A, Usen S, Jallow M, Richardson A, Hull J, Pinder M, Newport M, Kwiatkowski D.

J Infect Dis. 2002 Jun 1;185(11):1684-7. Epub 2002 May 17.

PMID:
12023780
18.

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW; European Study Group of Primary Sclerosing Cholangitis.

Gut. 2001 Aug;49(2):288-94.

19.

Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection.

Höhler T, Kruger A, Gerken G, Schneider PM, Meyer zum Büschenfelde KH, Rittner C.

J Med Virol. 1998 Mar;54(3):173-7.

PMID:
9515764
20.

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9.

Supplemental Content

Support Center